-
2
-
-
47349109646
-
Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies
-
Eckman JA, Hamilton RG, Gober LM, et al,. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 2008; 128: 1956-63.
-
(2008)
J Invest Dermatol
, vol.128
, pp. 1956-1963
-
-
Eckman, J.A.1
Hamilton, R.G.2
Gober, L.M.3
-
3
-
-
0027319492
-
Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria
-
Hide M, Francis DM, Grattan CE, et al,. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-604.
-
(1993)
N Engl J Med
, vol.328
, pp. 1599-1604
-
-
Hide, M.1
Francis, D.M.2
Grattan, C.E.3
-
4
-
-
0036010576
-
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: Comparison with the allergen-induced late-phase cutaneous reaction
-
Ying S, Kikuchi Y, Meng Q, et al,. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109: 694-700.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 694-700
-
-
Ying, S.1
Kikuchi, Y.2
Meng, Q.3
-
5
-
-
84874732930
-
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
-
Maurer M, Rosen K, Hsieh HJ, et al,. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 2013; 368: 924-35.
-
(2013)
N Engl J Med
, vol.368
, pp. 924-935
-
-
Maurer, M.1
Rosen, K.2
Hsieh, H.J.3
-
6
-
-
84878261946
-
TH2, allergy and group 2 innate lymphoid cells
-
Licona-Limon P, Kim LK, Palm NW, Flavell RA,. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013; 14: 536-42.
-
(2013)
Nat Immunol
, vol.14
, pp. 536-542
-
-
Licona-Limon, P.1
Kim, L.K.2
Palm, N.W.3
Flavell, R.A.4
-
7
-
-
80052026760
-
Role of IL-33 in inflammation and disease
-
Miller AM,. Role of IL-33 in inflammation and disease. J Inflamm (Lond) 2011; 8: 22.
-
(2011)
J Inflamm (Lond)
, vol.8
, pp. 22
-
-
Miller, A.M.1
-
8
-
-
53749093767
-
The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel 'alarmin'?
-
Moussion C, Ortega N, Girard JP,. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008; 3: e3331.
-
(2008)
PLoS One
, vol.3
, pp. e3331
-
-
Moussion, C.1
Ortega, N.2
Girard, J.P.3
-
9
-
-
34848899012
-
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex
-
Chackerian AA, Oldham ER, Murphy EE, et al,. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007; 179: 2551-5.
-
(2007)
J Immunol
, vol.179
, pp. 2551-2555
-
-
Chackerian, A.A.1
Oldham, E.R.2
Murphy, E.E.3
-
10
-
-
55149088554
-
Regulation and pro-inflammatory function of interleukin-17 family cytokines
-
Dong C,. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol Rev 2008; 226: 80-6.
-
(2008)
Immunol Rev
, vol.226
, pp. 80-86
-
-
Dong, C.1
-
11
-
-
79959821549
-
Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses
-
Corrigan CJ, Wang W, Meng Q, et al,. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 2011; 128: 116-24.
-
(2011)
J Allergy Clin Immunol
, vol.128
, pp. 116-124
-
-
Corrigan, C.J.1
Wang, W.2
Meng, Q.3
-
12
-
-
79952136459
-
T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma
-
Corrigan CJ, Wang W, Meng Q, et al,. T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci U S A 2011; 108: 1579-84.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 1579-1584
-
-
Corrigan, C.J.1
Wang, W.2
Meng, Q.3
-
13
-
-
33847134006
-
Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells
-
Allakhverdi Z, Comeau MR, Jessup HK, et al,. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204: 253-8.
-
(2007)
J Exp Med
, vol.204
, pp. 253-258
-
-
Allakhverdi, Z.1
Comeau, M.R.2
Jessup, H.K.3
-
14
-
-
66749190043
-
Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects
-
Corrigan CJ, Jayaratnam A, Wang Y, et al,. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects. Allergy 2009; 64: 1014-22.
-
(2009)
Allergy
, vol.64
, pp. 1014-1022
-
-
Corrigan, C.J.1
Jayaratnam, A.2
Wang, Y.3
-
15
-
-
84925260705
-
Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin
-
Kay AB, Ying S, Ardelean E, et al,. Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin. Br J Dermatol 2014; 171: 505-11.
-
(2014)
Br J Dermatol
, vol.171
, pp. 505-511
-
-
Kay, A.B.1
Ying, S.2
Ardelean, E.3
-
16
-
-
84904679524
-
CGRP and VEGF are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria
-
Kay AB, Ying S, Ardelean E, et al,. CGRP and VEGF are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria. Clin Exp Allergy 2014; 44: 1053-60.
-
(2014)
Clin Exp Allergy
, vol.44
, pp. 1053-1060
-
-
Kay, A.B.1
Ying, S.2
Ardelean, E.3
-
17
-
-
84898022112
-
2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: The 2013 revision and update
-
2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69: 868-87.
-
(2014)
Allergy
, vol.69
, pp. 868-887
-
-
Zuberbier, T.1
Aberer, W.2
Asero, R.3
-
18
-
-
34247265934
-
Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics
-
Kay AB, Ali FR, Heaney LG, et al,. Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics. Allergy 2007; 62: 495-503.
-
(2007)
Allergy
, vol.62
, pp. 495-503
-
-
Kay, A.B.1
Ali, F.R.2
Heaney, L.G.3
-
19
-
-
26244447845
-
Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse
-
Williams MJ, Lowrie MB, Bennett JP, et al,. Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse. Brain Res 2005; 1058: 62-72.
-
(2005)
Brain Res
, vol.1058
, pp. 62-72
-
-
Williams, M.J.1
Lowrie, M.B.2
Bennett, J.P.3
-
20
-
-
78650901948
-
Calcitonin gene-related peptide- and vascular endothelial growth factor-positive inflammatory cells in late-phase allergic skin reactions in atopic subjects
-
Kay AB,. Calcitonin gene-related peptide- and vascular endothelial growth factor-positive inflammatory cells in late-phase allergic skin reactions in atopic subjects. J Allergy Clin Immunol 2011; 127: 232-7.
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 232-237
-
-
Kay, A.B.1
-
21
-
-
12444341944
-
Toll-like receptors in innate immunity
-
Akira S, Takeda K,. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
-
(2005)
Int Immunol
, vol.17
, pp. 1-14
-
-
Akira, S.1
Takeda, K.2
-
22
-
-
84900430798
-
New insights in the pathogenesis of atopic dermatitis
-
Ong PY,. New insights in the pathogenesis of atopic dermatitis. Pediatr Res 2014; 75: 171-5.
-
(2014)
Pediatr Res
, vol.75
, pp. 171-175
-
-
Ong, P.Y.1
-
23
-
-
78650273552
-
IL-25 in atopic dermatitis: A possible link between inflammation and skin barrier dysfunction?
-
Hvid M, Vestergaard C, Kemp K, et al,. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 2011; 131: 150-7.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 150-157
-
-
Hvid, M.1
Vestergaard, C.2
Kemp, K.3
-
24
-
-
34547820890
-
IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells
-
Wang YH, Angkasekwinai P, Lu N, et al,. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204: 1837-47.
-
(2007)
J Exp Med
, vol.204
, pp. 1837-1847
-
-
Wang, Y.H.1
Angkasekwinai, P.2
Lu, N.3
-
25
-
-
78649821588
-
IL-33 is a crucial amplifier of innate rather than acquired immunity
-
Oboki K, Ohno T, Kajiwara N, et al,. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 2010; 107: 18581-6.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 18581-18586
-
-
Oboki, K.1
Ohno, T.2
Kajiwara, N.3
-
26
-
-
84890825282
-
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis
-
Salimi M, Barlow JL, Saunders SP, et al,. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013; 210: 2939-50.
-
(2013)
J Exp Med
, vol.210
, pp. 2939-2950
-
-
Salimi, M.1
Barlow, J.L.2
Saunders, S.P.3
-
27
-
-
84859158015
-
Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling
-
e6.
-
Nakajima S, Igyarto BZ, Honda T, et al,. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 2012; 129: 1048-55.e6.
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 1048-1055
-
-
Nakajima, S.1
Igyarto, B.Z.2
Honda, T.3
-
28
-
-
84859759522
-
IL-33: A novel danger signal system in atopic dermatitis
-
Cevikbas F, Steinhoff M,. IL-33: a novel danger signal system in atopic dermatitis. J Invest Dermatol 2012; 132: 1326-9.
-
(2012)
J Invest Dermatol
, vol.132
, pp. 1326-1329
-
-
Cevikbas, F.1
Steinhoff, M.2
-
29
-
-
77957787918
-
IL-33 is produced by mast cells and regulates IgE-dependent inflammation
-
Hsu CL, Neilsen CV, Bryce PJ,. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010; 5: e11944.
-
(2010)
PLoS One
, vol.5
, pp. e11944
-
-
Hsu, C.L.1
Neilsen, C.V.2
Bryce, P.J.3
-
30
-
-
0038276938
-
Mast cells produce interleukin-25 upon FcεRI-mediated activation
-
Ikeda K, Nakajima H, Suzuki K, et al,. Mast cells produce interleukin-25 upon FcεRI-mediated activation. Blood 2003; 101: 3594-6.
-
(2003)
Blood
, vol.101
, pp. 3594-3596
-
-
Ikeda, K.1
Nakajima, H.2
Suzuki, K.3
-
31
-
-
84860211299
-
Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines
-
Hepworth MR, Danilowicz-Luebert E, Rausch S, et al,. Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines. Proc Natl Acad Sci U S A 2012; 109: 6644-9.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 6644-6649
-
-
Hepworth, M.R.1
Danilowicz-Luebert, E.2
Rausch, S.3
-
32
-
-
84866015170
-
Regulation of type 2 immunity to helminths by mast cells
-
Hepworth MR, Maurer M, Hartmann S,. Regulation of type 2 immunity to helminths by mast cells. Gut Microbes 2012; 3: 476-81.
-
(2012)
Gut Microbes
, vol.3
, pp. 476-481
-
-
Hepworth, M.R.1
Maurer, M.2
Hartmann, S.3
-
33
-
-
84906571227
-
The alarmin IL-33 promotes regulatory T-cell function in the intestine
-
Schiering C, Krausgruber T, Chomka A, et al,. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014; 513: 564-8.
-
(2014)
Nature
, vol.513
, pp. 564-568
-
-
Schiering, C.1
Krausgruber, T.2
Chomka, A.3
|